PPBT实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States...

Stats
今日成交量	103 386
平均成交量	154 465
市值	13.77M
EPS	$0 ( 2024-03-06 )
下一个收益日期	( $-0.150 ) 2024-05-21
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.590
ATR14	$0.00900 (1.70%)

音量相关性

長: -0.35 (neutral)

短: -0.46 (neutral)

Signal:(42.476) Neutral

Purple Biotech Ltd. 相关性

10 最正相关
HALL	0.893
SNCR	0.877
NEXT	0.864
SBUX	0.862
LMNL	0.855
MTEK	0.833
NVIV	0.832
AYRO	0.827
RMRM	0.817
WTFC	0.817

10 最负相关
BNIXU	-0.942
BLZE	-0.872
ARTNA	-0.868
DOYU	-0.863
ACST	-0.852
FNKO	-0.844
ANZU	-0.841
CAMP	-0.832
CXSE	-0.831
WTBA	-0.829

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Purple Biotech Ltd. 相关性 - 货币/商品

-0.08
( neutral )

-0.13
( neutral )

0.00
( neutral )

Purple Biotech Ltd. 财务报表

Annual	2023
营收:	$0
毛利润:	$-199 000 (0.00 %)
EPS:	$-0.810

FY	2023
营收:	$0
毛利润:	$-199 000 (0.00 %)
EPS:	$-0.810

FY	2022
营收:	$-910 000
毛利润:	$-1.11M (122.09 %)
EPS:	$-1.130

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.050

Financial Reports:

No articles found.

Purple Biotech Ltd.

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer; and NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.